Live Science interviews Jonathan Lai, Ph.D., about his research engineering the first antibodies that can neutralize the most lethal strains of Ebola virus. Dr. Lai notes that these findings are the first significant step towards developing an all-inclusive treatment. Dr. Lai is associate professor of biochemistry at Einstein.
January 25, 2016
NY1 interviews Jonathan Lai, Ph.D., about his research on Ebola that focuses on developing antibodies to use as a possible treatment for all five strains of the virus. Dr. Lai notes that so far his lab has discovered antibodies that have proven protective in mice against the Sudan strain of the Ebola virus, but more research is required. Dr. Lai is associate professor of biochemistry.
More coverage on this story
New York Daily News
Chemical & Engineering News
Quartz
August 19, 2014